MIRA PHARMACEUTICALS, INC.MIRAEarnings & Financial Report
Nasdaq
MIRA Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on researching, developing, and commercializing novel prescription therapies for rare diseases and unmet medical needs. It primarily serves global patient populations, prioritizing therapeutic areas with limited existing treatment options to improve patient outcomes.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Brian McNulty, Individually and as Trustee of the Bay Shore Trust | 31.01% | 5.1M | ▼ -1.44pp | 2023-12-27 |
| George Cappy, Individually and as Trustee of the Bay Shore Trust | 23.88% | 3.8M | — | 2023-08-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.